An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Carboplatin Injection
Status: Discontinuation
»Therapeutic Categories: Oncology

Ingenus Pharmaceuticals LLC (Revised 12/01/2025)

Company Contact Information:
866-321-5031

Presentation	Posting Date	Related Information
Carboplatin, Injection, 450 mg/45 mL (NDC 50742-447-45)	12/01/2025	Discontinuation of the manufacture of the drug
Carboplatin, Injection, 600 mg/60 mL (NDC 50742-448-60)	12/01/2025	Discontinuation of the manufacture of the drug

Teyro Labs (New 03/28/2025)

Company Contact Information:
800-706-5575

Presentation	Posting Date	Related Information
Carboplatin, Injection, 10 mg/1 mL (NDC 60505-6282-3)	03/28/2025	Discontinuation due to low sales volume. Supply currently available with November 2025 expiry dating. Wholesaler & Distributor through Marketing partner (Apotex Inc.)
Carboplatin, Injection, 10 mg/1 mL (NDC 60505-6282-1)	03/28/2025	Discontinuation due to low sales volume. Supply currently available with June 2025 expiry dating. Wholesaler & Distributor through Marketing partner (Apotex Inc.)

Top